Earnings Preview: Longeveron to Report Financial Results Post-market on November 12

Moomoo NewsNov 6 20:00 ET

Longeveron to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

GlobeNewswireNov 4 16:05 ET

Peeling Back The Layers: Exploring Longeveron Through Analyst Insights

BenzingaNov 4 15:01 ET

Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

BenzingaOct 28 06:32 ET

Longeveron Said ELPIS I Met Its Primary Endpoint Of Safety Through 1-year Post-treatment, With 100% Survival Rate

BenzingaOct 27 16:48 ET

Express News | Longeveron Inc - Elpis II Phase 2B Clinical Trial Is Currently Ongoing

ReutersOct 27 15:10 ET